---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-117844"
form_type: "8-K"
ticker: "MDLN"
cik: "0002046386"
company_name: "Medline Inc."
filed_at: "2026-10-21T20:17:26+00:00"
generated_at: "2026-10-21T20:18:25.701722+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Medline exits all Medline Brand beds in voluntary field action; costs up to $220M vs $60M annual sales

## Summary
- Field action initiated Oct 14, 2026 covers homecare, bariatric and long-term care beds plus pendants, accessories, replacement parts and bed-containing order packages.
- Affected products posted net sales of about $60M for the 12 months ended June 27, 2026, within the Front Line Care category of the Medline Brand segment.
- Estimated costs of up to $220M cover discontinuation, inventory impairment, disposal and customer credits; booked in 2026-2027 and excluded from Adjusted EBITDA.
- Medline does not expect a material impact on FY2026 results or the full-year guidance issued Aug 5, 2026; actual customer credits may differ materially.

## SEC filing metadata
- accession: 0001104659-26-117844
- form_type: 8-K
- ticker: MDLN
- cik: 0002046386
- company_name: Medline Inc.
- filed_at: 2026-10-21T20:17:26+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2046386/000110465926117844/0001104659-26-117844-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2046386/000110465926117844/tm2627900d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-117844
- JSON: https://secwatch.observer/filing/0001104659-26-117844.json
- Plain text: https://secwatch.observer/filing/0001104659-26-117844.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.